Name : Apeiron (APRS)
APRS Price : $0.093 -2.12%
Consensus Mechanism : Proof of Stake
Volume: 2,907,197
Market Cap: 9,460,522
Shariah Judgement
This feature only can be accessed by subscribed users.
Shariah Status :
Last Screening: Q2 2024
Legitimacy:
Project:
Token:
Reward:
Shariah
Legitimacy
People
Shariah Analysis
Project/Products | Use Case | Status |
---|---|---|
Use Case | Status |
---|---|
System | Status | Interpretation |
---|---|---|
Legitimacy Analysis
Details | Status | |
---|---|---|
Whitepaper | ||
Project |
People Analysis
Details | Status | |
---|---|---|
Team |
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Overview
Apeiron is a dynamic god game inspired by classics like Populous, Black and White, and Spore, where players become a Godling, a newborn deity. You control a planet inhabited by cute creatures called doods, using divine powers to help or punish them. Beyond traditional god game mechanics, Apeiron features an Avatar system for exploring procedurally generated PvE dungeons and battling the forces of Chaos with a real-time card-battling system. It also includes a fast-paced PvP mode where players can compete in the Godling Arena. The game's universe, inspired by global mythology and folklore, offers a collaborative living story with seasonal updates, epic Guild vs Guild battles, and large-scale Raid Boss encounters.
Whitepaper & Documents
Sharlife uses TradingView technology to present price information through charts. TradingView serves as a charting platform catering to a worldwide community of traders and investors. With robust support across browsers, desktops, and mobile applications, the platform offers exceptional access to real-time data such as Dow Futures and BTC USD Chart, as well as the latest news, financial reports, stock screener, and economic .
COMMENTS
0 Comments